Eli Lilly 21 may 2026 Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial | Eli Lilly and Company - investor.lilly.com
Harvard Bioscience 21 may 2026 Harvard Bioscience stock (US4169061052): Q2 2025 mixed results still define the story - AD HOC NEWS
Agilent 21 may 2026 New Agilent detector finds trace chemicals in drugs, food and water - Stock Titan
Eli Lilly 21 may 2026 Lilly, BMS, Incyte strike deals to keep biopharma’s AI integration rolling - BioSpace
Cell 21 may 2026 Scavenger receptor class F member 2 is an intracellular receptor for hepatitis B virus
Recursion 21 may 2026 Can Altitude Lab’s Early Wins Reframe Recursion Pharmaceuticals’ (RXRX) High-Burn Platform Bet? - Sahm
Eli Lilly 21 may 2026 Eli Lilly maintains M&A streak with $202m Engage Bio buyout - Pharmaceutical Technology
FierceBiotech 21 may 2026 Infex, following in Insmed’s footsteps, advances lung disease candidate after clearing phase 2a
Thermo Fisher 21 may 2026 Thermo Fisher Scientific’s SWOT analysis: stock navigates growth amid strategic shifts - Investing.com
Membrane Solutions 21 may 2026 New Leadership for MANN+HUMMEL’s Air Filtration and Water Membrane Solutions Business - mann+hummel
Membrane Solutions 21 may 2026 PVDF Membrane Market Size, Share | Industry Report, 2033 - Grand View Research